The effectiveness of reperfusion therapies can vary based on factors such as the timeliness of intervention, the type of therapy used, and the patient’s overall health condition. For instance, early administration of thrombolytic agents can significantly reduce mortality in patients experiencing an acute myocardial infarction. Similarly, primary PCI, when performed within the recommended time window, has been shown to be more effective than thrombolysis in reducing death and recurrent ischemic events.
